ID   TICRR_HUMAN             Reviewed;        1910 AA.
AC   Q7Z2Z1; B2RE07; B3KVV9; D3IUT4; Q8N4X8; Q8NCH6; Q9BU55;
DT   24-JUL-2007, integrated into UniProtKB/Swiss-Prot.
DT   24-JUL-2007, sequence version 2.
DT   15-MAR-2017, entry version 103.
DE   RecName: Full=Treslin;
DE   AltName: Full=TopBP1-interacting checkpoint and replication regulator;
DE   AltName: Full=TopBP1-interacting, replication-stimulating protein;
GN   Name=TICRR; Synonyms=C15orf42;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND FUNCTION.
RX   PubMed=20116089; DOI=10.1016/j.cell.2009.12.049;
RA   Kumagai A., Shevchenko A., Shevchenko A., Dunphy W.G.;
RT   "Treslin collaborates with TopBP1 in triggering the initiation of DNA
RT   replication.";
RL   Cell 140:349-359(2010).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 134-367 (ISOFORM 1), AND
RP   VARIANT CYS-287.
RA   Stevens M., Wei C., Gross S.S., McPherson J., Brent M.R.;
RT   "Exhaustive RT-PCR and sequencing of all novel TWINSCAN predictions in
RT   human.";
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 635-1910, AND VARIANTS
RP   CYS-1523; THR-1718 AND CYS-1885.
RC   TISSUE=Teratocarcinoma, Tongue, and Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 901-1910.
RC   TISSUE=Rectum tumor;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1321-1910, AND VARIANT
RP   CYS-1523.
RC   TISSUE=Lung, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-441, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1307 AND SER-1413, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1026; THR-1307 AND
RP   SER-1484, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH TOPBP1.
RX   PubMed=20080954; DOI=10.1101/gad.1860310;
RA   Sansam C.L., Cruz N.M., Danielian P.S., Amsterdam A., Lau M.L.,
RA   Hopkins N., Lees J.A.;
RT   "A vertebrate gene, ticrr, is an essential checkpoint and replication
RT   regulator.";
RL   Genes Dev. 24:183-194(2010).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-441; SER-599; SER-820;
RP   SER-838; SER-923; SER-1001 AND SER-1078, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-292; SER-441; SER-599;
RP   SER-838; SER-865; SER-923; SER-938; SER-1001; SER-1026; SER-1057;
RP   SER-1078; SER-1125; THR-1134 AND SER-1484, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Regulator of DNA replication and S/M and G2/M
CC       checkpoints. Regulates the triggering of DNA replication
CC       initiation via its interaction with TOPBP1 by participating in
CC       CDK2-mediated loading of CDC45L onto replication origins. Required
CC       for the transition from pre-replication complex (pre-RC) to pre-
CC       initiation complex (pre-IC). Required to prevent mitotic entry
CC       after treatment with ionizing radiation.
CC       {ECO:0000269|PubMed:20116089}.
CC   -!- SUBUNIT: Interacts with TOPBP1 (via BRCT domains); interaction
CC       takes place in a CDK2-dependent manner.
CC       {ECO:0000269|PubMed:20080954}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20080954}.
CC       Note=Associates with chromatin.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q7Z2Z1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q7Z2Z1-2; Sequence=VSP_039218;
CC   -!- SIMILARITY: Belongs to the treslin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC11165.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAG38104.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAG53921.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; GQ227787; ADC30133.1; -; mRNA.
DR   EMBL; AC013391; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC013787; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; DR731357; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK074727; BAC11165.1; ALT_INIT; mRNA.
DR   EMBL; AK123612; BAG53921.1; ALT_INIT; mRNA.
DR   EMBL; AK315750; BAG38104.1; ALT_INIT; mRNA.
DR   EMBL; BX538335; CAD98102.1; -; mRNA.
DR   EMBL; BC002881; AAH02881.2; -; mRNA.
DR   EMBL; BC033209; AAH33209.2; -; mRNA.
DR   CCDS; CCDS10352.2; -. [Q7Z2Z1-1]
DR   CCDS; CCDS76791.1; -. [Q7Z2Z1-2]
DR   RefSeq; NP_001294954.1; NM_001308025.1. [Q7Z2Z1-2]
DR   RefSeq; NP_689472.3; NM_152259.3. [Q7Z2Z1-1]
DR   UniGene; Hs.441708; -.
DR   ProteinModelPortal; Q7Z2Z1; -.
DR   BioGrid; 124706; 4.
DR   IntAct; Q7Z2Z1; 2.
DR   STRING; 9606.ENSP00000268138; -.
DR   iPTMnet; Q7Z2Z1; -.
DR   PhosphoSitePlus; Q7Z2Z1; -.
DR   BioMuta; TICRR; -.
DR   DMDM; 156631024; -.
DR   EPD; Q7Z2Z1; -.
DR   MaxQB; Q7Z2Z1; -.
DR   PaxDb; Q7Z2Z1; -.
DR   PeptideAtlas; Q7Z2Z1; -.
DR   PRIDE; Q7Z2Z1; -.
DR   Ensembl; ENST00000268138; ENSP00000268138; ENSG00000140534. [Q7Z2Z1-1]
DR   Ensembl; ENST00000560985; ENSP00000453306; ENSG00000140534. [Q7Z2Z1-2]
DR   GeneID; 90381; -.
DR   KEGG; hsa:90381; -.
DR   UCSC; uc002boe.4; human. [Q7Z2Z1-1]
DR   CTD; 90381; -.
DR   DisGeNET; 90381; -.
DR   GeneCards; TICRR; -.
DR   H-InvDB; HIX0012567; -.
DR   HGNC; HGNC:28704; TICRR.
DR   HPA; HPA049454; -.
DR   HPA; HPA055024; -.
DR   MIM; 613298; gene.
DR   neXtProt; NX_Q7Z2Z1; -.
DR   OpenTargets; ENSG00000140534; -.
DR   PharmGKB; PA142672278; -.
DR   eggNOG; ENOG410IFG8; Eukaryota.
DR   eggNOG; ENOG410Y8R6; LUCA.
DR   GeneTree; ENSGT00390000005222; -.
DR   HOVERGEN; HBG101933; -.
DR   InParanoid; Q7Z2Z1; -.
DR   OMA; HSASFYS; -.
DR   OrthoDB; EOG091G0WBD; -.
DR   PhylomeDB; Q7Z2Z1; -.
DR   TreeFam; TF332114; -.
DR   GenomeRNAi; 90381; -.
DR   PRO; PR:Q7Z2Z1; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000140534; -.
DR   CleanEx; HS_C15orf42; -.
DR   ExpressionAtlas; Q7Z2Z1; baseline and differential.
DR   Genevisible; Q7Z2Z1; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0000075; P:cell cycle checkpoint; ISS:UniProtKB.
DR   GO; GO:0006281; P:DNA repair; ISS:UniProtKB.
DR   GO; GO:0006260; P:DNA replication; ISS:UniProtKB.
DR   GO; GO:0001731; P:formation of translation preinitiation complex; ISS:UniProtKB.
DR   GO; GO:0033314; P:mitotic DNA replication checkpoint; ISS:UniProtKB.
DR   GO; GO:0030174; P:regulation of DNA-dependent DNA replication initiation; IMP:UniProtKB.
DR   GO; GO:0010212; P:response to ionizing radiation; ISS:UniProtKB.
DR   InterPro; IPR026153; Treslin.
DR   InterPro; IPR032746; Treslin_N.
DR   PANTHER; PTHR21556; PTHR21556; 1.
DR   Pfam; PF15292; Treslin_N; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell cycle; Complete proteome; DNA damage;
KW   DNA repair; Nucleus; Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN         1   1910       Treslin.
FT                                /FTId=PRO_0000296623.
FT   COMPBIAS   1193   1378       Pro-rich.
FT   MOD_RES     292    292       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     441    441       Phosphoserine.
FT                                {ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     599    599       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     820    820       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     838    838       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     865    865       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     923    923       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     938    938       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1001   1001       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1026   1026       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1057   1057       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1078   1078       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1125   1125       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1134   1134       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1141   1141       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8BQ33}.
FT   MOD_RES    1307   1307       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332}.
FT   MOD_RES    1413   1413       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1484   1484       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     312    312       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:20116089}.
FT                                /FTId=VSP_039218.
FT   VARIANT     287    287       R -> C (in dbSNP:rs10775247).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_050886.
FT   VARIANT     402    402       R -> W (in dbSNP:rs11629584).
FT                                /FTId=VAR_050887.
FT   VARIANT     628    628       R -> C (in dbSNP:rs3743372).
FT                                /FTId=VAR_034631.
FT   VARIANT     747    747       V -> A (in dbSNP:rs12905387).
FT                                /FTId=VAR_050888.
FT   VARIANT     923    923       S -> C (in dbSNP:rs16943377).
FT                                /FTId=VAR_050889.
FT   VARIANT    1523   1523       R -> C (in dbSNP:rs894157).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_050890.
FT   VARIANT    1718   1718       S -> T (in dbSNP:rs1866928).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_050891.
FT   VARIANT    1885   1885       R -> C (in dbSNP:rs3743372).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_050892.
FT   CONFLICT    152    152       N -> Y (in Ref. 3; DR731357).
FT                                {ECO:0000305}.
FT   CONFLICT    336    336       K -> T (in Ref. 3; DR731357).
FT                                {ECO:0000305}.
FT   CONFLICT   1009   1009       S -> G (in Ref. 1; ADC30133 and 4;
FT                                BAG53921). {ECO:0000305}.
FT   CONFLICT   1344   1344       Q -> L (in Ref. 4; BAG38104).
FT                                {ECO:0000305}.
FT   CONFLICT   1373   1373       V -> I (in Ref. 4; BAG53921).
FT                                {ECO:0000305}.
FT   CONFLICT   1427   1427       L -> P (in Ref. 4; BAC11165).
FT                                {ECO:0000305}.
FT   CONFLICT   1667   1667       W -> R (in Ref. 4; BAC11165).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1910 AA;  210857 MW;  3E726E5091B9FA5B CRC64;
     MACCHKVMLL LDTAGGAARH SRVRRAALRL LTYLSCRFGL ARVHWAFKFF DSQGARSRPS
     RVSDFRELGS RSWEDFEEEL EARLEDRAHL PGPAPRATHT HGALMETLLD YQWDRPEITS
     PTKPILRSSG RRLLDVESEA KEAEAALGGL VNAVFLLAPC PHSQRELLQF VSGCEAQAQR
     LPPTPKQVME KLLPKRVREV MVARKITFYW VDTTEWSKLW ESPDHLGYWT VCELLHHGGG
     TVLPSESFSW DFAQAGEMLL RSGIKLSSEP HLSPWISMLP TDATLNRLLY NSPEYEASFP
     RMEGMLFLPV EAGKEIQETW TVTLEPLAMH QRHFQKPVRI FLKGSVAQWS LPTSSTLGTD
     SWMLGSPEES TATQRLLFQQ LVSRLTAEEL HLVADVDPGE GRPPITGVIS PLSASAMILT
     VCRTKEAEFQ RHVLQTAVAD SPRDTASLFS DVVDSILNQT HDSLADTASA ASPVPEWAQQ
     ELGHTTPWSP AVVEKWFPFC NISGASSDLM ESFGLLQAAS ANKEESSKTE GELIHCLAEL
     YQRKSREEST IAHQEDSKKK RGVPRTPVRQ KMNTMCRSLK MLNVARLNVK AQKLHPDGSP
     DVAGEKGIQK IPSGRTVDKL EDRGRTLRSS KPKDFKTEEE LLSYIRENYQ KTVATGEIML
     YACARNMIST VKMFLKSKGT KELEVNCLNQ VKSSLLKTSK SLRQNLGKKL DKEDKVRECQ
     LQVFLRLEMC LQCPSINEST DDMEQVVEEV TDLLRMVCLT EDSAYLAEFL EEILRLYIDS
     IPKTLGNLYN SLGFVIPQKL AGVLPTDFFS DDSMTQENKS PLLSVPFLSS ARRSVSGSPE
     SDELQELRTR SAKKRRKNAL IRHKSIAEVS QNLRQIEIPK VSKRATKKEN SHPAPQQPSQ
     PVKDTVQEVT KVRRNLFNQE LLSPSKRSLK RGLPRSHSVS AVDGLEDKLD NFKKNKGYHK
     LLTKSVAETP VHKQISKRLL HRQIKGRSSD PGPDIGVVEE SPEKGDEISL RRSPRIKQLS
     FSRTHSASFY SVSQPKSRSV QRVHSFQQDK SDQRENSPVQ SIRSPKSLLF GAMSEMISPS
     EKGSARMKKR SRNTLDSEVP AAYQTPKKSH QKSLSFSKTT PRRISHTPQT PLYTPERLQK
     SPAKMTPTKQ AAFKESLKDS SSPGHDSPLD SKITPQKRHT QAGEGTSLET KTPRTPKRQG
     TQPPGFLPNC TWPHSVNSSP ESPSCPAPPT SSTAQPRREC LTPIRDPLRT PPRAAAFMGT
     PQNQTHQQPH VLRAARAEEP AQKLKDKAIK TPKRPGNSTV TSSPPVTPKK LFTSPLCDVS
     KKSPFRKSKI ECPSPGELDQ KEPQMSPSVA ASLSCPVPST PPELSQRATL DTVPPPPPSK
     VGKRCRKTSD PRRSIVECQP DASATPGVGT ADSPAAPTDS RDDQKGLSLS PQSPPERRGY
     PGPGLRSDWH ASSPLLITSD TEHVTLLSEA EHHGIGDLKS NVLSVEEGEG LRTADAEKSS
     LSHPGIPPSP PSCGPGSPLM PSRDVHCTTD GRQCQASAQL DNLPASAWHS TDSASPQTYE
     VELEMQASGL PKLRIKKIDP SSSLEAEPLS KEESSLGEES FLPALSMPRA SRSLSKPEPT
     YVSPPCPRLS HSTPGKSRGQ TYICQACTPT HGPSSTPSPF QTDGVPWTPS PKHSGKTTPD
     IIKDWPRRKR AVGCGAGSSS GRGEVGADLP GSLSLLESEG KDHGLELSIH RTPILEDFEL
     EGVCQLPDQS PPRNSMPKAE EASSWGQFGL SSRKRVLLAK EEADRGAKRI CDLREDSEVS
     KSKEGSPSWS AWQLPSTGDE EVFVSGSTPP PSCAVRSCLS ASALQALTQS PLLFQGKTPS
     SQSKDPRDED VDVLPSTVED SPFSRAFSRR RPISRTYTRK KLMGTWLEDL
//
